PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 20, 2019Biomedicines166 citationsOpen Access

Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis

JCJorge CorrealeMMMariano MarrodánMYMaría Célica Ysrraelit

Key Points

  • To review the underlying cellular and molecular mechanisms driving neurodegeneration, axonal damage, and progressive disability in multiple sclerosis.
  • Narrative review synthesizing pathological pathways involved in progressive multiple sclerosis, focusing on central nervous system compartmentalized immune reactions, metabolic dysfunction, and structural degradation.
  • Compartmentalized central nervous system immune responses—including B-cell dysregulation, CD8⁺ T-cell activity, and microglial activation—drive cortical demyelination and neuritic transection.
  • Reactive oxygen and nitrogen species combined with mitochondrial dysfunction cause intra-axonal calcium accumulation, activating catabolic enzymes that degrade cytoskeletal proteins.
  • Impaired trophic and metabolic support from dysfunctional oligodendrocytes further accelerates axonal degeneration and irreversible neuronal loss.

Abstract

Multiple Sclerosis (MS) is a major cause of neurological disability, which increases predominantly during disease progression as a result of cortical and grey matter structures involvement. The gradual accumulation of disability characteristic of the disease seems to also result from a different set of mechanisms, including in particular immune reactions confined to the Central Nervous System such as: (a) B-cell dysregulation, (b) CD8⁺ T cells causing demyelination or axonal/neuronal damage, and (c) microglial cell activation associated with neuritic transection found in cortical demyelinating lesions. Other potential drivers of neurodegeneration are generation of oxygen and nitrogen reactive species, and mitochondrial damage, inducing impaired energy production, and intra-axonal accumulation of Ca2+, which in turn activates a variety of catabolic enzymes ultimately leading to progressive proteolytic degradation of cytoskeleton proteins. Loss of axon energy provided by oligodendrocytes determines further axonal degeneration and neuronal loss. Clearly, these different mechanisms are not mutually exclusive and could act in combination. Given the multifactorial pathophysiology of progressive MS, many potential therapeutic targets could be investigated in the future. This remains however, an objective that has yet to be undertaken.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Correale et al. (2019) studied this question.

synapsesocial.com/papers/69d8557833ca018b39ae3946https://doi.org/10.3390/biomedicines7010014
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes1997 · 349 citations
  2. 2Proteasome-Mediated Reduction in Proapoptotic Molecule Bim Renders CD4 + CD28 null T Cells Resistant to Apoptosis in Acute Coronary Syndrome2014 · 47 citations
  3. 3Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis2018 · 152 citations
  4. 4The Immunopathology of Multiple Sclerosis: An Overview2007 · 1,192 citations
  5. 5Grey matter pathology in multiple sclerosis2008 · 514 citations